<DOC>
	<DOCNO>NCT01931007</DOCNO>
	<brief_summary>The overall goal study develop regenerative cell therapy use patient osteoarthritis ( OA ) . The primary objective proposal conduct pilot study assess safety feasibility use concentrate bone marrow aspirate contain MSC treat patient painful knee OA .</brief_summary>
	<brief_title>Use Autologous Bone Marrow Aspirate Concentrate Painful Knee Osteoarthritis</brief_title>
	<detailed_description>Patients symptomatic mild moderate bilateral knee osteoarthritis candidate pilot study . Baseline data include radiograph , MRI imaging , clinical data knee pain analysis synovial fluid inflammatory marker . Bone marrow aspirate patient 's iliac crest cellular rich portion concentrate . Randomly , one knee inject bone marrow concentrate . The contralateral knee inject sterile saline placebo . Follow-up analysis synovial fluid one week 6 month injection ; clinical data obtain 3 , 6 12 month MRI image perform 6 month injection , repeat radiographs 12 month</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Male Female subject eligible 2 . Subjects must 18 year age old 3 . Subjects must bilateral OA pain knee . 4 . Osteoarthritis may primary secondary . Knees must KellgrenLawrence Grades 13 . 5 . Subjects must previously try 6 week one follow conservative treatment Activity modification , weight loss ; physical therapy , antiinflammatory injection therapy 6 . Patients provide write informed consent nature study fully explain 1 . Patients abnormal hematology , serum chemistry , urinalysis screen laboratory result . 2 . Patients take antiinflammatory medication ( prescription overthecounter ) , include herbal therapy , within 14 day baseline visit . 3 . Patients take antirheumatic disease medication ( include methotrexate antimetabolite ) within 3 month prior study entry . 4 . Patients receive injection treat knee within 2 month prior study entry . 5 . Patients pregnant currently breastfeed child . 6 . Patients systemic , rheumatic inflammatory disease knee chondrocalcinosis , hemochromatosis , inflammatory arthritis , arthropathy knee associate juxtaarticular Paget 's disease femur tibia , ochronosis , hemophilic arthropathy , infectious arthritis , Charcot 's knee joint , villonodular synovitis , synovial chondromatosis . 7 . Patients ongoing infectious disease , include HIV hepatitis 8 . Patients clinically significant cardiovascular , renal , hepatic , endocrine disease , cancer , diabetes 9 . Patients participate study experimental drug medical device within 30 day study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>osteoarthritis</keyword>
</DOC>